Microgenetics: our story
20 March 2018
Since our establishment in 2014, Microgenetics has been working to develop cutting-edge technology for the pharmaceutical sector, to provide time and money saving products which will revolutionise the way pharmaceutical microbiology is carried out.
June: In response to the death of a number of very young children who had been administered a non-sterile product before sterility tests were completed, we asked the question ‘How can we improve traditional sterility testing methods?’. We then commenced our research collaboration with Dr Ruth Massey and Dr Maisem Laabei, who were based at the time at the University of Bath. Ruth assisted in developing ideas for a new sterility test which would remove the need to culture microorganisms, and Maisem began developing our revolutionary technology.
December: After working on our new sterility test for several months we realised this solution could be useful to the pharmaceutical industry in general, not just to us. We therefore decided to create Microgenetics, which was officially incorporated in December
May: Dr Leann Bacon joined our team as an academic researcher, and continued developing and streamlining the test into a marketable product.
January: In response to changes to data integrity requirements by regulatory bodies, a need was identified for a better way of recording and managing environmental monitoring data for QC teams in the pharmaceutical sector. This led to the idea for the SmartControl environmental monitoring software, which was designed to allow smart, paperless record-keeping for busy QC staff.
December: By the end of 2016 Leann had definitively shown that our sterility test (named ‘SwiftDetect’) could detect contamination down to a single cell in any sample volume.
Ongoing work was done in this period to refine the SwiftDetect test so that we could achieve a result in the shortest possible space of time. Turnaround time was reduced to under 6 hours.
May: Development was complete for the temperature and pressure environmental monitoring software, which would later form part of SmartControl.
July: Our academic collaborators from the University of Bath relocated to the University of Bristol.
December: Tammy Hassel was appointed Director of Microgenetics.
January: Validation work began on our SwiftDetect test to begin the process of bringing the product to market.